bcl-6 Antibody (DA005)
bcl-6 Antibody (DA005)
Recombinant monoclonal rabbit antibody
Description
BCL6 is a transcriptional regulator gene which codes for a 706-amino-acid nuclear zinc finger protein.1 In normal tissue these antibodies have strong nuclear staining for a subset of B-lymphocytes, mostly located in germinal centers (GC).2 BCL6 antibodies stain malignant cells in follicular lymphoma,3 diffuse large B-cell lymphomas,4 Burkitt lymphoma,4 classical Hodgkin lymphoma,5 as well as majority of tumor cells in nodular lymphocyte predominant Hodgkin lymphoma.6 BCL6 expression has been also seen in anaplastic large cell lymphomas (ALCL).7
References
1. Falini B, et al. Bcl-6 protein expression in normal and neoplastic lymphoid tissues. Ann Oncol. 1997; 2: 101-4.
2. Aukema SM, et al. Double-hit B-cell lymphomas. Blood 2011; 117:2319-31.
3. Dogan A, et al. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol. 2000; 24:846-52.
4. Carbone A, et al. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. Hum Pathol. 2010; 41:621-31.
5. Bai M, et al. B-cell differentiation immunophenotypes in classical Hodgkin lymphomas. Leuk Lymphoma. 2006; 47:495-501.
6. Carbone A, et al. Expression of BCL-6 protein and CD138/syndecan-1 as B-cell markers in Hodgkin's disease. Int J Biol Markers 1999; 14:144-8.
7.Saglam A, et al. Immunohistochemical expression of Mum-1, Oct-2 and Bcl-6 in systemic anaplastic large cell lymphomas. Tumori. 2011; 97:634-8.
2. Aukema SM, et al. Double-hit B-cell lymphomas. Blood 2011; 117:2319-31.
3. Dogan A, et al. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol. 2000; 24:846-52.
4. Carbone A, et al. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. Hum Pathol. 2010; 41:621-31.
5. Bai M, et al. B-cell differentiation immunophenotypes in classical Hodgkin lymphomas. Leuk Lymphoma. 2006; 47:495-501.
6. Carbone A, et al. Expression of BCL-6 protein and CD138/syndecan-1 as B-cell markers in Hodgkin's disease. Int J Biol Markers 1999; 14:144-8.
7.Saglam A, et al. Immunohistochemical expression of Mum-1, Oct-2 and Bcl-6 in systemic anaplastic large cell lymphomas. Tumori. 2011; 97:634-8.
Specifications
Application:
IHC (FFPE)
Host:
Rabbit
Subclass:
IgG
Immunogen:
Synthetic peptide from human Bcl-6
Cellular location:
Cytoplasm
Control:
Tonsil
Order information
| RMB1A051 | Concentrate | IVD(R) |
| RMB1A051 | 10 ml Ready to use | IVD(R) |
| RMB1A051 | 6 ml Ready to use | IVD(R) |
| RMB1A051 | 3 ml Ready to use | IVD(R) |
